A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.
Ontology highlight
ABSTRACT: The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high prevalence and easy transmission, which is expanding globally with no conventional treatment or vaccine. The new virus revealed 79% and 50% genomic similarities with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively. Accordingly, since the disease resists testing and adopting new therapeutics, repositioning pre-existing drugs may present a fast and attractive strategy with known safety, characteristics, and dosage used. However, they are not specific and targeted. Therefore, several drugs have been investigated for their efficacy and safety in the treatment of COVID-19; most of them are undergoing clinical trials. This article su
SUBMITTER: Tarighi P
PROVIDER: S-EPMC7816644 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA